LASERME
Unleash the best of your skin
NON-ABLATIVE SKIN RESURFACING TREATMENTLaserMe is a portable non-ablative fractional laser for dermatological procedures effective to treat a wide range of skin imperfections
LaserMe is a non-ablative fractional laser, equipped with a diode laser.
The device delivers optimal wavelength through the scanning handpiece that creates microscopic columns of wounded tissue. Local tissue moisture vaporises rapidly and cells undergo lysis, necrosis and solidification, resulting in rejuvenation and tightening of the skin and stimulating new collagen production 1 .
LaserMe includes more than 40 levels of multiple fractional laser scans and 3 different size scanning options - 100%, 50%,10%- for a customised treatment.
The diode laser incorporated in LaserMe has an optimal wavelength of 1470 nm and a maximal fluence per micro-thermal zone of 5-50 mJ/MTZ. LaserMe output power is 2W and a pulse width 3-30 ms.
LASERME HANDPIECE
The ergonomic and lightweight LaserMe handpiece uses an innovative microfiber with precise scanner. It covers a large size of treatment area 12 x 12 mm, which can be adjusted selecting the percentage of the window to be filled (100%,50%, 10%) with 1-4 mm spot spacing. The handpiece is fitted with a contact sensor which protects both patient and practitioner, ensuring the correct performance of the treatment.
LASERME HANDPIECE
The ergonomic and lightweight LaserMe handpiece uses an innovative microfiber with precise scanner. It covers a large size of treatment area 12 x 12 mm, which can be adjusted selecting the percentage of the window to be filled (100%,50%, 10%) with 1-4 mm spot spacing. The handpiece is fitted with a contact sensor which protects both patient and practitioner, ensuring the correct performance of the treatment.
LASERME is a IIb class Medical Device regulated health products which bears, under this regulation MDD 93/42, the CE mark. Manufacturer: B&K, Domaniewska 37, Warsaw, Poland. Please carefully read the instructions in the leaflets. The use of this product requires the intervention of a healthcare professional.
*FDA clearance for treatment of benign pigmented lesions, such as, but not limited to lentigines (age spots), solar lentigos (sun spots), melasma, dyschromia, and for treatment of facial wrinkles and fine lines.
1.Data on file